LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | AON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 24 July 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD |
|
|
||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
248,992 |
0.11% |
1,612,068 |
0.70% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
549,040 |
0.24% |
29,700 |
0.01% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
798,032 |
0.34% |
1,641,768 |
0.71% |
||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 13 |
208.1000 USD |
Purchase | 53 |
207.0700 USD |
Purchase | 95 |
206.5200 USD |
Purchase | 98 |
206.8300 USD |
Purchase | 100 |
207.7800 USD |
Purchase | 100 |
206.8200 USD |
Purchase | 100 |
207.2000 USD |
Purchase | 100 |
207.0300 USD |
Purchase | 170 |
207.0417 USD |
Purchase | 196 |
207.0529 USD |
Purchase | 209 |
207.7194 USD |
Purchase | 218 |
207.5410 USD |
Purchase | 219 |
207.1866 USD |
Purchase | 307 |
207.2654 USD |
Purchase | 354 |
207.0400 USD |
Purchase | 428 |
206.7681 USD |
Purchase | 539 |
207.0577 USD |
Purchase | 584 |
207.0708 USD |
Purchase | 740 |
206.9799 USD |
Purchase | 946 |
206.9172 USD |
Purchase | 1,572 |
206.9919 USD |
Purchase | 1,999 |
207.0008 USD |
Purchase | 2,200 |
207.1200 USD |
Purchase | 2,282 |
207.4263 USD |
Purchase | 3,356 |
207.1700 USD |
Purchase | 7,524 |
207.1222 USD |
Purchase | 8,168 |
206.9884 USD |
Purchase | 12,549 |
207.1224 USD |
Purchase | 34,148 |
207.2147 USD |
Purchase | 44,695 |
207.0036 USD |
Sale | 1 |
206.9500 USD |
Sale | 20 |
206.8700 USD |
Sale | 38 |
206.9300 USD |
Sale | 98 |
206.8300 USD |
Sale | 100 |
207.0000 USD |
Sale | 100 |
207.1100 USD |
Sale | 120 |
207.2033 USD |
Sale | 153 |
207.0700 USD |
Sale | 200 |
206.9900 USD |
Sale | 200 |
207.0125 USD |
Sale | 200 |
207.1000 USD |
Sale | 200 |
207.4950 USD |
Sale | 201 |
207.0300 USD |
Sale | 270 |
206.8966 USD |
Sale | 300 |
207.0900 USD |
Sale | 500 |
206.9740 USD |
Sale | 510 |
206.8962 USD |
Sale | 539 |
207.0577 USD |
Sale | 600 |
207.2233 USD |
Sale | 600 |
206.9866 USD |
Sale | 775 |
207.2850 USD |
Sale | 810 |
207.0343 USD |
Sale | 816 |
207.1841 USD |
Sale | 824 |
207.2819 USD |
Sale | 902 |
206.8904 USD |
Sale | 1,059 |
207.0400 USD |
Sale | 1,100 |
207.1200 USD |
Sale | 1,320 |
206.9950 USD |
Sale | 1,615 |
206.9573 USD |
Sale | 1,700 |
207.4238 USD |
Sale | 1,903 |
207.0588 USD |
Sale | 2,471 |
207.0286 USD |
Sale | 2,915 |
207.0292 USD |
Sale | 3,061 |
207.1700 USD |
Sale | 3,221 |
206.9552 USD |
Sale | 3,241 |
206.9768 USD |
Sale | 3,452 |
207.2949 USD |
Sale | 4,297 |
207.3194 USD |
Sale | 4,831 |
206.9968 USD |
Sale | 6,682 |
207.3448 USD |
Sale | 11,178 |
207.0656 USD |
Sale | 12,057 |
207.1294 USD |
Sale | 12,582 |
207.1723 USD |
Sale | 14,491 |
206.9955 USD |
Sale | 21,791 |
207.0299 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 27 Jul 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |